Vera Therapeutics, Inc. Class A
(NASDAQ: VERA)

Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA.

44.508 -

-0.602 (-1.33%)
Range 44.490 - 45.745   (2.82%)
Open 44.950
Previous Close 45.110
Bid Price 44.490
Bid Volume 101
Ask Price 44.630
Ask Volume 5
Volume 109,140
Value 3,812,441
Remark -
Delayed prices. Updated at 29 Jan 2026 23:56.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis